Hutson Nancy J
CIK 0001379222
Director
Filings
13
Latest Jun 16, 2025
Issuers covered
3
Showing
13 of 13
Page 1
Track record
3 of 5 open-market trades scored (60% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +1.7% | +0.3% | +10.2% | -5.3% |
| 90 days | 3 | 67% | +13.6% | +12.6% | +28.2% | -0.1% |
| 180 days | 3 | 67% | +2.1% | +15.2% | +32.1% | -40.9% |
| 365 days | 3 | 67% | +29.8% | +21.5% | +68.5% | -0.8% |
Issuers
Companies where Hutson Nancy J has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals Inc | 6 | Jun 16, 2025 |
| CLSD | Clearside Biomedical, Inc. | 4 | Jun 21, 2024 |
| PHAS | Phasebio Pharmaceuticals Inc | 3 | May 19, 2023 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|